Effect of Sofosbuvir Administration and Its Withdrawal on the Submandibular Salivary Gland of Adult Male Albino Rats: A Histological and Ultra-Structural Study

BACKGROUND: Sofosbuvir (SOF) was approved in 2013 as a part of first-line treatment for hepatitis C virus (HCV); it has activity against all genotypes with extrahepatic adverse effects have recently arisen. AIM: Investigating sofosbuvir-induced alterations in the rat submandibular salivary gland (SM...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdeen, Asmaa Mahmoud, Essawy, Tarik, Mohammed, Saher Sayed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Dental Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061369/
https://www.ncbi.nlm.nih.gov/pubmed/32165960
http://dx.doi.org/10.3889/oamjms.2019.868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061369/
https://www.ncbi.nlm.nih.gov/pubmed/32165960
http://dx.doi.org/10.3889/oamjms.2019.868

Ejemplares similares